Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Medication adherence at SPITEX Basel
Project funded by own resources
Project title Medication adherence at SPITEX Basel
Principal Investigator(s) Arnet, Isabelle
Co-Investigator(s) Hersberger, Kurt
Project Members Beeler, Angela
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Pharmaceutical Care (Hersberger)
Project start 06.01.2018
Probable end 31.12.2019
Status Completed
Abstract

SPITEX stands for "spitalexterne Hilfe, Gesundheits- und Krankenpflege" and is an organisaion providing care and support services to individuals of all ages at home. When a person newly applies for SPITEX services, a case manager will assess patient needs during a first visit and use the tool Resident Assessment Instrument-Home Care (RAI-HC). Within this tool, the Minimum Data Set (MDS) contains the question P6 that assesses medication adherence. The case manager estimates if the client is adhrent to his/her medication «always», «80% of the time or more» or «less than 80% of the time». We aim at investigating the subjective criteria used by the case managers of SPITEX Basel to assess patient medication adherence, and to explore whether the question P6 and the answer options are appropriate. We will perform a secondary  analysis of first MDS assessments in 2017/2018 and focus groud discussion with SPITEX case managers.

Keywords medication adherende, SPITEX Basel, estimation, Minimum Data Set (MDS)
Financed by University funds

Cooperations ()

  ID Kreditinhaber Kooperationspartner Institution Laufzeit - von Laufzeit - bis
4526333  Arnet, Isabelle  Ceccarelli, Paola, Qualitätsmanagement  SPITEX Basel  01.01.2018  31.12.2022 
   

MCSS v5.8 PRO. 0.428 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024